Chartwell Investment Partners LLC Grows Stock Position in The Cigna Group (NYSE:CI)

Chartwell Investment Partners LLC grew its stake in The Cigna Group (NYSE:CI - Free Report) by 17.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,252 shares of the health services provider's stock after buying an additional 3,877 shares during the quarter. Chartwell Investment Partners LLC's holdings in The Cigna Group were worth $9,095,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CI. Cedar Wealth Management LLC purchased a new position in The Cigna Group in the 1st quarter worth approximately $29,000. TruNorth Capital Management LLC purchased a new position in The Cigna Group during the second quarter valued at $33,000. Ulland Investment Advisors LLC grew its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Harbor Capital Advisors Inc. purchased a new position in shares of The Cigna Group during the third quarter valued at about $45,000. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of The Cigna Group in the second quarter worth about $66,000. Institutional investors own 86.99% of the company's stock.

Insider Transactions at The Cigna Group

In related news, Director William J. Delaney III sold 2,691 shares of the business's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.60% of the company's stock.

Analyst Ratings Changes

A number of analysts have issued reports on CI shares. Piper Sandler reaffirmed an "overweight" rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a research note on Monday, November 4th. Barclays lifted their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. Jefferies Financial Group upped their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the company a "buy" rating in a research report on Tuesday, September 17th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $400.00 price target on shares of The Cigna Group in a research note on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $394.64.

The Cigna Group Stock Up 7.9 %

NYSE:CI traded up $25.11 during midday trading on Monday, reaching $344.88. 1,590,088 shares of the stock traded hands, compared to its average volume of 1,535,051. The business has a 50-day moving average of $341.73 and a two-hundred day moving average of $340.26. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a 12-month low of $253.95 and a 12-month high of $370.83. The stock has a market capitalization of $95.93 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 0.96 and a beta of 0.51.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, topping analysts' consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to analysts' expectations of $59.58 billion. During the same quarter last year, the firm earned $6.77 EPS. The business's quarterly revenue was up 29.8% on a year-over-year basis. On average, equities analysts forecast that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.62%. The Cigna Group's payout ratio is 52.83%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.